Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

Slides:



Advertisements
Similar presentations
What's New in Basal Insulin for Diabetes
Advertisements

Multimodal Management of Opioid-Induced Constipation
Short-, Intermediate-, Long-Acting Insulins
Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors.
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
Clinical Trials in IBD.
Monitoring and Modifying Treatment in PAH
Applying Data to Practice
Statin Selection Aimed to Reduce New-Onset DM Risk:
An Update on Oral Prostanoids: Advancing Care for PAH?
New Patient-Friendly Options for Managing Insulin Dosing
Glaucoma Progression.
Overview of Disparities
SGLT2 Inhibitors and Their Clinical Impact:
Modern Strategies for Basal Insulin Use in T2D
Insulin Innovation.
Insulin/GLP-1 Agonist Combinations
New Perspectives in AF and PCI: Implications for the Practicing Physician.
Extended Half-life Factor Products in the Management of Hemophilia
Program Goals. Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin.
Agenda. Insulin Intensification Strategies: An Expert Perspective from Asia-Pacific.
How Early Should Basal Insulin Be Used in T2D Management?
How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients
Updates Abound.
Working as a Team for Improved Patient Outcomes in Type 2 Diabetes
What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?
Innovative Insulin Combinations: A New strategy for the Person With T2DM.
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
Tailoring Hemophilia Prophylaxis Therapy
Emerging Basal Insulins for Diabetes
GLP-1 Receptor Agonists: How Early Is Appropriate?
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Talking to Patients About Diabetes Management
Clinical Updates in RA: New Developments and Insights From Washington
Moving Prostate Cancer Care Forward: Putting Lessons From New Orleans and Chicago Into Practice.
Applying Real-World Evidence in Atrial Fibrillation Into Clinical Care:
The future of urate-lowering strategies for gout
Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?
WHO Clinical Classification of PH Complex Cases in PH.
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Insulin/GLP-1 Agonist Combinations
Insulin Use in Primary Care: Practice Challenges
Insulin Innovation.
New Horizons in Adjunctive Type 1 Diabetes Management With SGLT Inhibitors.
LEADER One Year On.
Simplifying Insulin Delivery for Better Patient Outcomes in T2D
Predictive Low Glucose Suspend (PLGS)
T2DM Management.
Better Diabetes Control With Novel Basal Insulins
Modern Advances in Glucose Monitoring
When Is Intrathecal Drug Delivery Appropriate?
Program. Basal Insulin in the Modern Era The CDE's Role in Improving Utilization and Outcomes.
Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.
Extended Half-life Factor Products in the Management of Hemophilia
Insulin Innovation.
Hypoglycemia: The Most Common Barrier to Effective Diabetes Management
Insulin in Diabetes Management: Effective Patient Selection Is Key
Statins, Obesity, and Hyperlipidemia
PEARLS OF WISDOM WITH COMBINATION THERAPY IN PAH
COMBINATIONS AND COFORMULATIONS: THE FUTURE OF INSULIN THERAPY?
Challenges in LA SCCHN.
Improving Effective Basal Insulin Use in Clinical Practice
When Is Intrathecal Drug Delivery Appropriate?
Emerging Combination Injectable Therapy A New Era in Diabetes Care
PAH Pathways: What Do the Data Tell Us?”
Practical Strategies for Overcoming Emotional Barriers to Insulin Initiation in the Primary Care Setting.
Fixed-Ratio Combination Therapy in T2DM
Emerging Basal Insulins for Diabetes
Fresh perspectives ON BASAL Insulins in diabetes care
Presentation transcript:

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

Program Overview

Basal Insulin/GLP-1 RA: Fixed-Ratio Combinations

Glucose-Lowering Therapy Options

Personalizing Therapy According to Patient’s Glucose Profile

Ideal Patient Profile for Basal Insulin/GLP-1 RA

Barriers to Using Basal Insulin/GLP-1 RA in Primary Care

Barriers to Using Basal Insulin/GLP-1 RA in Primary Care (cont)

Using Basal Insulin/GLP-1 RA in Clinical Practice—IGlarLixi

Using Basal Insulin/GLP-1 RA in Clinical Practice—IDegLira

Insulin Dose

Summary

Abbreviations

Abbreviations (cont)